Neogenomics Ratios (2010-2026) | NEO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Profitability
Gross Margin (Quarter)	38.93%	35.99%	32.63%	35.14%	37.97%	40.97%	39.95%	40.77%	41.01%	43.45%	41.90%	44.07%	44.62%	44.92%	43.59%	42.61%	42.84%	43.83%	43.32%	45.56%
EBT Margin (Quarter)	-19.10%	-35.16%	-45.37%	-32.81%	-30.77%	-18.40%	-24.57%	-18.13%	-14.12%	-9.83%	-17.72%	-11.56%	-10.64%	-9.38%	-15.27%	-25.27%	-14.05%	-6.52%	-9.42%	0.91%
EBIT Margin (Quarter)	-32.73%	-33.06%	-44.40%	-31.74%	-30.68%	-19.02%	-25.56%	-20.35%	-15.92%	-11.94%	-19.56%	-13.34%	-12.63%	-10.70%	-16.56%	-26.27%	-14.38%	-7.05%	-9.77%	-4.85%
EBITDA Margin (Quarter)	-32.73%	-33.06%	-44.40%	-31.74%	-30.68%	-19.02%	-25.56%	-20.35%	-15.92%	-11.94%	-19.56%	-13.34%	-12.63%	-10.70%	-16.56%	-26.27%	-14.38%	-7.05%	-9.77%	-4.85%
Operating Margin (Quarter)	-32.73%	-33.06%	-44.40%	-31.74%	-30.68%	-19.02%	-25.56%	-20.35%	-15.92%	-11.94%	-19.56%	-13.34%	-12.63%	-10.70%	-16.56%	-26.27%	-14.38%	-7.05%	-9.77%	-4.85%
Net Margin (Quarter)	-16.77%	-33.21%	-42.17%	-28.23%	-28.62%	-16.36%	-22.44%	-16.56%	-12.19%	-9.21%	-17.32%	-11.33%	-10.55%	-8.91%	-15.43%	-24.87%	-14.45%	-5.20%	-9.16%	1.11%
FCF Margin (Quarter)	-18.74%	-25.26%	-31.80%	-21.82%	-18.73%	-5.93%	-16.48%	-6.15%	-6.43%	6.90%	-20.16%	0.49%	-0.93%	-1.05%	-17.75%	7.72%	0.30%	-3.43%	-7.04%	5.82%
Efficiency
Inventory Average (Quarter)	21.61M	22.61M	23.62M	22.85M	22.83M	24.04M	24.35M	24.69M	24.50M	24.10M	22.24M	21.77M	23.84M	25.60M	28.26M	31.97M	31.32M	28.51M	29.20M	28.49M
Assets Average (Quarter)	1,901.35M	1,888.08M	1,849.66M	1,810.83M	1,773.85M	1,747.81M	1,724.60M	1,702.14M	1,686.67M	1,679.73M	1,660.78M	1,641.81M	1,642.19M	1,639.57M	1,619.73M	1,497.69M	1,384.37M	1,367.31M	1,353.18M	1,349.39M
Invested Capital (Quarter)
Asset Utilization Ratio (Quarter)	0.25	0.26	0.26	0.27	0.28	0.29	0.31	0.32	0.34	0.35	0.37	0.38	0.39	0.40	0.42	0.46	0.51	0.53	0.55	0.57
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-1.18	-32.65	-1.55	-1.18	-1.18	-5.06	-1.07	-0.91	-0.74	10.06	-0.93	-0.67	-0.65	-4.59	-0.85	-1.59	-0.90	-22.39	-0.62	-0.33
Debt Ratio (Quarter)
Times Interest Earned (Quarter)	-1.18	-32.65	-1.55	-1.18	-1.18	-5.06	-1.07	-0.91	-0.74	10.06	-0.93	-0.67	-0.65	-4.59	-0.85	-1.59	-0.90	-22.39	-0.62	-0.33
Valuation
Enterprise Value (Quarter)	-542.71M	-515.39M	-481.43M	-465.95M	-443.54M	-437.99M	-417.92M	-409.35M	-402.26M	-415.20M	-384.83M	-387.86M	-387.81M	-386.84M	-358.08M	-163.69M	-164.12M	-159.62M	-146.14M	-145.54M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-3.96%	-6.59%	-8.81%	-10.01%	-10.23%	-9.51%	-8.59%	-8.14%	-7.25%	-6.80%	-6.52%	-7.05%	-6.86%	-6.88%	-6.67%	-8.23%	-9.40%	-9.06%	-8.38%	-5.50%
Return on Invested Capital (Quarter)
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Developers

Neogenomics Ratios (2010-2026) | NEO

Research Tools

Developers

Neogenomics Ratios (2010-2026) | NEO

Create an account

Sign In

Reset Password